Provided by Tiger Fintech (Singapore) Pte. Ltd.

eFFECTOR Therapeutics, Inc.

0.0002
0.0000
Volume:283.00
Turnover:0.06
Market Cap:940.88
PE:0.00
High:0.0002
Open:0.0002
Low:0.0002
Close:0.0002
52wk High:0.0500
52wk Low:0.0000
Shares:4.70M
Float Shares:4.58M
Volume Ratio:1.21
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.4244
EPS(LYR):-16.3748
ROE:-946.56%
ROA:-83.33%
PB:0.00
PE(LYR):0.00

Loading ...

Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 05, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 30, 2024

Major Issues Report

Form 8-K - Current report
Jan 27, 2024

Major Issues Report

Form 8-K - Current report
Jan 10, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 28, 2023

Major Issues Report

Form 8-K - Current report
Nov 23, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Sep 16, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 11, 2023

Major Issues Report

Form 8-K - Current report
Aug 18, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
Jun 22, 2023

Correspondence

Form CORRESP - Correspondence
Jun 20, 2023

Major Issues Report

Form 8-K - Current report